Brain mineralocorticoid receptors and centrally regulated functions

Kidney International

Volumn 57, Issue 4, 2000, Pages 1329-1336

  De Kloet, E Ronald ^a,b   Van Acker, Saskia A B E ^a,b   Sibug, Rosana M ^a,b   Oitzl, Melly S ^a,b   Meijer, Onno C ^a,b   Rahmouni, Kamal ^a,b   De Jong, Wybren ^a,b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Brain; Cardiovascular regulation; Glucocorticoids; Hippocampal neurons; Mineralocorticoids; Stress response

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; GLUCOCORTICOID RECEPTOR; GLYCOPROTEIN P; MINERALOCORTICOID RECEPTOR; RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE;

AUTONOMIC INNERVATION; CONFERENCE PAPER; FLUID BALANCE; HORMONE ACTION; LIMBIC SYSTEM; NEUROENDOCRINOLOGY; NONHUMAN; ORGAN DISTRIBUTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SODIUM BALANCE; STRESS;

EID: 0034087496     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00971.x     Document Type: Conference Paper

References (30)

1. 1. DE KLOET ER, REUL JMHM: Feedback action and tonic influence of corricosteroids on brain function: A concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 12:83-105, 1987
2. 2. DE KLOET ER: Brain corticosteroid balance and homeostatic control. Front Neuroendocrinol 12:95-164, 1991
3. 3. DE KLOET ER, VREUGDENHII E, OITZL MS, JOËLS M: Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301, 1998
4. 4. SECKL JR: 11β-Hydroxysteroid dehydrogenase in the brain: A novel regulator of glucocorticoid action? Front Neuroendocrinol 18:49-99, 1997
5. 5. MEIJER OC, LANGE ECM, BREIMER DD, DE BOER AG, WORKEL JO, DE KLOET ER: Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 139:1789-1793, 1998
6. 6. REUL JMHM, DE KLOET ER: Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation. Endocrinology 117:2505-2511, 1985
7. 7. VAN STEENSEL B, VAN BINNENDUK EP, HONRSBY CD, VAN DER VOORT HTM, KROZOWSKI ZS, DE KLOET ER, VAN DRIEL R: Partial colocalization of glucocorticoid and mineralocorticoid receptors in discrete compartments in nuclei of rat hippocampus neurons. J Cell Sci 109:787-792, 1996
8. 8. PEARCE D, YAMAMOTO KR: Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 259:1161-1165, 1993
9. 9. COLE TJ, BLENDY JA, MONAGHAN AP, KRIEFGLSTEIN K, SCHMID W, AGUZZI A, FANTUZZI G, HUMLER E, UNSICKER K, SCHÜTZ G: Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 9:1608-1621, 1995
10. 10. HLSEN W, KARTST H, MEIJER OC, COLE TJ, SCHMID W, DE KLOET ER, SCHÜTZ G, JOËLS M: Hippocampal cell responses in mice with a targeted glucocorticoid receptor gene disruption. J Neurosci 16:6766-6774, 1996
11. 11. OITZL MS, DE KLOET ER, JOELS M, SCHMID W, COLE TJ: Spatial learning deficits in mice with a targeted glucocorticoid receptor gene disruption. Eur J Neurosci 9:2284-2296, 1997
12. 12. REICHARDT HM, KAESTNER KH, TUCKERMANN J, KRETZ O, WESSFLY O, BOCK R, GASS P, SCHMID W, HERRLICH P, ANGEL P, SCHÜTZ G: DNA hinding of the glucocorticoid receptor is not essential for survival. Cell 93:531-541, 1998
13. 13. JOËLS M: Steroid hormones and excitability in the mammalian brain. Front Neuroendocrinol 18:2-48, 1997
14. 14. DE KLOET ER, ROTS NY, VAN DEN BERG DTWM, OITZL MS: Brain mineralocorticoid receptor function, in Corticosteroid Receptors: Studies on the Mechanism, Function, and Neurotoxicity of Corticosteroid Action Annals of the New York Academy of Sciences (vol 746), New York, New York Academy of Science, 1994, pp 8-21
15. 15. OITZL M, DE KLOET ER: Selective corticosteroid-antagonists modulate specific aspects of spatial orientation learning. Behav Neurosci 106:62-71, 1992
16. 16. OITZL MS, FLUTTERT MFJ, DE KLOET ER: The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticosteroid receptors. Eur J Neurosci 6:1072-1079, 1994
17. 17. BRODY MJ, VARNER KL, VASQUEZ EC, LEWIS SJ: Central nervous system and the pathogenesis of hypertension. Sites and mechanisms. Hypertension 18(Suppl 5):III7-12, 1991
18. 18. VAN DEN BERG DTWM, DE KLOET ER, VAN DIJKEN HH, DE JONG W: Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure. Endocrinology 126:118-124, 1990
19. 19. VAN DEN BERG DTWM, DE JONG W, DE KLOET ER: Mineralocorticoid antagonist inhibits stress-induced blood pressure response after repeated daily warming. Am J Physiol 267(6 Pt 1):E921-E926, 1994
20. 20. VAN DEN BERG DTWM, DE KLOET ER, DE JONG W: Central effects of mineralocorticoid antagonist RU-28318 on blood pressure of DOCA-salt hypertensive rats. Am J Physiol 267(6 Pt 1):E927-E933, 1994
21. 21. GOMEZ-SANCHEZ EP: Central hypertensive effects of aldosterone. Front Neuroendocrinol 18:440-462, 1997
22. 22. RAHMOUNT K, BARTHELMEPS M, GRIMA M, IMBS JL, DE JONG W: Brain mineralocorticoid receptor control of blood pressure and kidney function in normotensive rats. Hypertension 33:1201-1206, 1999
23. 23. RATKA A, SUTANTO W, BLOFMERS M, DE KLOET ER: On the role of mineralocorticoid (type 1) and glucocorticoid (type 2) receptors in neuro-endocrine regulation. Neuroendocrinology 50:117-123, 1989
24. 24. OITZL MS, VAN HAARST AD, SUTANTO W, DE KLOET ER: Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: The Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis. Psychoneuroendocrinology 20:655-677, 1995
25. 25. CAREY MP, DETERD CH, DE KONING J, HELMERHORST FM, DE KLOET ER: The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. J Endocrinol 144:311-321, 1995
26. 26. VAN EEKELEN JAM, OITZL MS, DE KLOET ER: Adrenocortical hyporesponsiveness and glucocorticoid feedback resistance in old male Brown Norway rats. J Gerontol 50A:B83-B89, 1995
27. 27. HOLSBOER F, BARDEN N: Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 17:187-205, 1996
28. 28. SCHÖBITZ B, SUTANTO W, CAREY MP, HOLSBOER F, DE KLOET ER: Endotoxin and interleukin-1 decrease the affinity of hippocampal mineralocorticoid (type 1) receptor in parallel to activation of the hypothalamic-pituitary-adrenal axis. Neuroendocrinology 60:124-133, 1994
29. 29. VAN HAARST AD, OITZL MS, DE KLOET ER: Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus. Neurochem Res 22:1323-1328, 1997
30. 30. JOËLS M, DE KLOET ER: Mineralocorticoid and glucocorticoid receptors in the brain: Implications for ion permeability and transmitter systems. Prog Neurobiol 43:1-36, 1994